EMERAM Capital Partners-backed Meona Group to acquire Dr. Heni SOFTWARE.

EMERAM Capital Partners-backed, Meona Group, company in the field of clinical software, acquires Dr. Heni SOFTWARE, a provider of high-performance software products which support pharmacists in the preparation, prescription and billing of cytostatic solutions. Financial terms were not disclosed. With its software, Meona offers a forward-thinking solution for efficient patient care and patient management in hospitals and other facilities. Through the combination with the Belgian company E.care bvba, which develops software to support hospital treatment processes, Meona had already expanded its product range to include the product E.care ED, a process management control solution with intuitive treatment documentation for emergency rooms, in 2017. "Over many years, Dr. Heni has created efficient solutions for hospital pharmacies that are geared toward the needs of the market. We are very pleased to be able to complete the medication workflow with the integration of his solution and to offer the organization of the complex production of cytostatic drugs from a single source,” PD Dr. med. Tobias Schäfer, Meona Joint Managing Director and CEO.